Opsumit data published today

Discussion in 'Actelion' started by Anonymous, Aug 30, 2013 at 8:15 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Mortality/Morbidity benefits look great!
     

  2. Anonymous

    Anonymous Guest

    What a joke. What mortality benefit?
     
  3. Anonymous

    Anonymous Guest

    After the software install that fixed the problem.
     
  4. Anonymous

    Anonymous Guest

    Do you are saying they tweeted the numbers?
     
  5. Anonymous

    Anonymous Guest

    Absolutely!
     
  6. Anonymous

    Anonymous Guest

    Hum, no surprise there!
     
  7. Anonymous

    Anonymous Guest

    Tweeted? Or Tweaked?
     
  8. Anonymous

    Anonymous Guest

    What happened to launch within 6 months? That was back in Feb 2012! Hahahaha
    Someone on this board was very optimistic.
     
  9. Anonymous

    Anonymous Guest

    When the hell is this REALLY gonna launch? I don't believe anything I hear anymore.
     
  10. Anonymous

    Anonymous Guest

    FDA just loves Actelion
    You will get a non approval, no benefit to patient
    How about that generic Tracleer coming soon to a patient near you
     
  11. Anonymous

    Anonymous Guest

    Flat out wrong.
     
  12. Anonymous

    Anonymous Guest

    You might be able to buy off your handful of physicians left but good luck with the FDA!
     
  13. Anonymous

    Anonymous Guest

    Why the hell would the FDA approve Maci when there is absolutely no clear benefit over Bosentan?? The "mortality/morbidity" data is just a made up endpoint which doesn't differentiate Maci from any other therapy. FDA will see through the shenanigans and request more efficacy data. Bank it!!!
     
  14. Anonymous

    Anonymous Guest

    True about the endpoint, it will be approved.
     
  15. Anonymous

    Anonymous Guest

    What benefit does it bring to the patient? Generic will be written over Mac.
     
  16. Anonymous

    Anonymous Guest

    Maci is nothing more than a money grab by an arrogant and opportunistic company. This is equivalent to the extended release formulations on way too many drugs that get approved just before patent expiration on the original compound. Nothing more and we should be ashamed to represent this kind of greed, then talk about "patients first"!!
     
  17. Anonymous

    Anonymous Guest

    Lets wait and see the results of their recent marketing surveys, that are paying doctors $100, to buy their, I mean share their interest in Maci. Oh, if you are wondering what I'm talking about ask your local rep they are the ones handing out the pre-launch, completely illegal survey.
     
  18. Anonymous

    Anonymous Guest

    If this is true it is certainly illegal.